EMEA-000249-PIP01-08 - paediatric investigation plan
Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B
PIPHuman
MedImmune, LLC
E-mail: dekkere@medimmune.com
Country: United States
Telephone: +1 3013984040
P/101/2008: European Medicines Agency decision of 3 November 2008 on the application for product specific waiver for influenza virus type A, H3N2, influenza virus type A, H1N1, influenza virus type B (EMEA-000249-PIP01-0...